Sifaprazine

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameSifaprazine

Drug Alias NameFI-4303

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsDepressive Disorder, Major

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySpain

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesFerrer

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesFerrer

Active IndicationsN/A

Inactive IndicationsDepressive Disorder, Major

ATC CodeN/A